We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

Cardiovascular · Menopause

Menopause and cholesterol: why numbers shift and what to do

You lived through your 30s with perfect lipid panels. Then at 50, your LDL jumped 40 points and your HDL slid. You didn't change your diet. Menopause changed your metabolism. Understanding what's happening — and treating it early — is one of the highest-leverage interventions in a woman's midlife.

The menopause lipid signature

  • LDL up 10–15%
  • HDL down 5–10%
  • Triglycerides up 15–25%
  • ApoB up (particle number rises)
  • Small dense LDL fraction increases

Treatment framework

  1. Baseline ApoB, lipid panel, Lp(a), HbA1c, and 10-year ASCVD risk
  2. HRT if within window and symptomatic — often improves lipids
  3. Statin if ASCVD risk high or LDL >190 or ApoB >130
  4. Diet: prioritize protein, fiber, reduce refined carbs
  5. Resistance training + zone 2 cardio

Frequently asked questions

Why does cholesterol worsen in menopause?

Estrogen upregulates LDL receptors in the liver. When estrogen drops, LDL clearance slows and LDL rises. HDL also drops. Triglycerides increase.

Does HRT improve cholesterol?

Yes. Oral estrogens raise HDL and lower LDL dramatically, though they also raise triglycerides. Transdermal is neutral-to-favorable overall with better safety.

HRT or statin for cholesterol?

Not either/or. If ASCVD risk is high, statin. If in the HRT window and symptomatic, both. HRT is not a substitute for statins in high-risk patients.

What is the "window of opportunity"?

Starting HRT within 10 years of menopause (or before age 60) confers cardiovascular benefit. Starting later may not — timing matters.

What about ApoB and Lp(a)?

ApoB is a better cardiovascular predictor than LDL. Lp(a) is genetic and doesn't change with lifestyle. Both should be measured once in midlife.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.

Ask Dot